Pricing
  1. JP-listed companies
  2. Ina Research Inc.
  3. Financials
  4. Cash from operations

Ina Research Inc. (E20922)

Market cap
P/E ratio
Inari Research provides contract testing services to help pharmaceutical companies evaluate drug safety and effectiveness using GLP-compliant laboratory facilities.
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2022690+57.42%
Mar 31, 2021439+61.97%
Mar 31, 2020271-390.75%
Mar 31, 2019-93-114.45%
Mar 31, 2018644-33229.20%
Mar 31, 2017-2-98.87%
Mar 31, 2016-171-236.89%
Mar 31, 2015125-40.16%
Mar 31, 2014209+1521.57%
Mar 31, 201313

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat